Jean-Paul Achkar, MD

Article

Ulcerative colitis: Responding to the challenges

Author:: Jean-Paul Achkar, MD

Publish date: September 1, 2007

Aminosalicylates are the first-line therapy for patients with mild to moderate active ulcerative colitis. Infliximab is now approved for moderately...